Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 12.5B | 12.1B | 11.9B | 11.8B |
Cost of revenue | 4.6B | 4.2B | 4.2B | 4.0B |
Gross profit | 7.9B | 7.9B | 7.8B | 7.8B |
Operating expense | ||||
Research & development | 2.0B | 2.0B | 2.0B | 1.9B |
Selling general and admin | 3.0B | 3.0B | 2.9B | 3.0B |
Other operating expenses | — | — | — | — |
Operating income | 2.7B | 2.8B | 2.7B | 2.6B |
Non operating interest income | ||||
Income | 193.4M | 213.0M | 202.8M | 243.7M |
Expense | 313.6M | 343.4M | 344.3M | 356.2M |
Other income expense | 15.3M | -115.9M | -59.7M | -531.8M |
Pretax income | 2.6B | 2.5B | 2.5B | 1.9B |
Tax provision | 382.6M | 388.6M | 391.2M | -378.4M |
Net income | 2.2B | 2.1B | 2.1B | 2.3B |
Basic EPS | — | 0.6 | 0.6 | 0.7 |
Diluted EPS | — | 0.6 | 0.6 | 0.7 |
Basic average shares | — | 3.4B | 3.4B | 3.4B |
Diluted average shares | — | 3.4B | 3.4B | 3.4B |
EBITDA | 3.4B | 3.5B | 3.5B | 3.5B |
Net income from continuing op. | 2.2B | 2.1B | 2.1B | 2.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |